RESUMEN
Embryo implantation remains a significant challenge for assisted reproductive technology, with implantation failure occurring in â¼50% of in vitro fertilization attempts. Understanding the molecular mechanisms underlying uterine receptivity will enable the development of new interventions and biomarkers. TGFß family signaling in the uterus is critical for establishing and maintaining pregnancy. Follistatin (FST) regulates TGFß family signaling by selectively binding TGFß family ligands and sequestering them. In humans, FST is up-regulated in the decidua during early pregnancy, and women with recurrent miscarriage have lower endometrial expression of FST during the luteal phase. Because global knockout of Fst is perinatal lethal in mice, we generated a conditional knockout (cKO) of Fst in the uterus using progesterone receptor-cre to study the roles of uterine Fst during pregnancy. Uterine Fst-cKO mice demonstrate severe fertility defects and deliver only 2% of the number of pups delivered by control females. In Fst-cKO mice, the uterine luminal epithelium does not respond properly to estrogen and progesterone signals and remains unreceptive to embryo attachment by continuing to proliferate and failing to differentiate. The uterine stroma of Fst-cKO mice also responds poorly to artificial decidualization, with lower levels of proliferation and differentiation. In the absence of uterine FST, activin B expression and signaling are up-regulated, and bone morphogenetic protein (BMP) signals are impaired. Our findings support a model in which repression of activin signaling by FST enables uterine receptivity by preserving critical BMP signaling.
Asunto(s)
Decidua/fisiología , Folistatina/fisiología , Útero/fisiología , Animales , Modelos Animales de Enfermedad , Implantación del Embrión/fisiología , Femenino , Fertilización In Vitro , Folistatina/deficiencia , Folistatina/genética , Humanos , Infertilidad Femenina/fisiopatología , Subunidades beta de Inhibinas/metabolismo , Masculino , Ratones , Ratones de la Cepa 129 , Ratones Endogámicos C57BL , Ratones Noqueados , Embarazo , Transducción de SeñalRESUMEN
The dorsal ventral axis of vertebrates requires high BMP activity for ventral development and inhibition of BMP activity for dorsal development. Presumptive dorsal regions of the embryo are protected from the ventralizing activity of BMPs by the secretion of BMP antagonists from the mesoderm. Noggin, one such antagonist, binds BMP ligands and prevents them from binding their receptors, however, a unique role for Noggin in amphibian development has remained unclear. Previously, we used zinc-finger nucleases to mutagenize the noggin locus in Xenopus tropicalis. Here, we report on the phenotype of noggin mutant frogs as a result of breeding null mutations to homozygosity. Early homozygous noggin mutant embryos are indistinguishable from wildtype siblings, with normal neural induction and neural tube closure. However, in late tadpole stages mutants present severe ventral craniofacial defects, notably a fusion of Meckel's cartilage to the palatoquadrate cartilage. Consistent with a noggin loss-of-function, mutants show expansions of BMP target gene expression and the mutant phenotype can be rescued with transient BMP inhibition. These results demonstrate that in amphibians, Noggin is dispensable for early embryonic patterning but is critical for cranial skeletogenesis.
Asunto(s)
Región Branquial/crecimiento & desarrollo , Proteínas Portadoras/fisiología , Proteínas de Xenopus/fisiología , Xenopus/crecimiento & desarrollo , Alelos , Animales , Tipificación del Cuerpo , Proteínas Morfogenéticas Óseas/farmacología , Proteínas Morfogenéticas Óseas/fisiología , Proteínas Portadoras/genética , Cartílago/anomalías , Diferenciación Celular , Embrión no Mamífero/metabolismo , Embrión no Mamífero/ultraestructura , Folistatina/deficiencia , Folistatina/genética , Técnicas de Inactivación de Genes , Glicoproteínas/deficiencia , Glicoproteínas/genética , Homocigoto , Péptidos y Proteínas de Señalización Intercelular/deficiencia , Péptidos y Proteínas de Señalización Intercelular/genética , Larva , Mandíbula/anomalías , Morfolinos/farmacología , Cráneo/anomalías , Xenopus/embriología , Proteínas de Xenopus/deficiencia , Proteínas de Xenopus/genéticaRESUMEN
Myostatin (MSTN) and growth and differentiation factor-11 (GDF-11) are highly related TGF-ß family members that have distinct biological functions. MSTN is expressed primarily in skeletal muscle and acts to limit muscle growth. GDF-11 is expressed more widely and plays multiple roles, including regulating axial skeletal patterning during development. Several MSTN and GDF-11 binding proteins have been identified, including GDF-associated serum protein-1 (GASP-1) and GASP-2, which are capable of inhibiting the activities of these ligands. Here, we show that GASP-1 and GASP-2 act by blocking the initial signaling event (namely, the binding of the ligand to the type II receptor). Moreover, we show that mice lacking Gasp1 and Gasp2 have phenotypes consistent with overactivity of MSTN and GDF-11. Specifically, we show that Gasp2(-/-) mice have posteriorly directed transformations of the axial skeleton, which contrast with the anteriorly directed transformations seen in Gdf11(-/-) mice. We also show that both Gasp1(-/-) and Gasp2(-/-) mice have reductions in muscle weights, a shift in fiber type from fast glycolytic type IIb fibers to fast oxidative type IIa fibers, and impaired muscle regeneration ability, which are the reverse of what are seen in Mstn(-/-) mice. All of these findings suggest that both GASP-1 and GASP-2 are important modulators of GDF-11 and MSTN activity in vivo.
Asunto(s)
Proteínas Morfogenéticas Óseas/metabolismo , Proteínas Portadoras/metabolismo , Factores de Diferenciación de Crecimiento/metabolismo , Miostatina/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Animales , Tipificación del Cuerpo/genética , Proteínas Morfogenéticas Óseas/antagonistas & inhibidores , Proteínas Morfogenéticas Óseas/deficiencia , Huesos/embriología , Huesos/metabolismo , Cardiotoxinas , Proteínas Portadoras/genética , Folistatina/deficiencia , Folistatina/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Factores de Diferenciación de Crecimiento/antagonistas & inhibidores , Factores de Diferenciación de Crecimiento/deficiencia , Péptidos y Proteínas de Señalización Intracelular , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patología , Mutación/genética , Miostatina/antagonistas & inhibidores , Miostatina/genética , Tamaño de los Órganos , Oxidación-Reducción , Unión Proteica , Proteínas Serina-Treonina Quinasas/metabolismo , Receptor Tipo II de Factor de Crecimiento Transformador beta , Receptores Acoplados a Proteínas G/deficiencia , Receptores Acoplados a Proteínas G/genética , Receptores de Factores de Crecimiento Transformadores beta/metabolismo , Regeneración/genética , Transducción de Señal/genéticaRESUMEN
Wnt4(-/-) XX gonads display features normally associated with testis differentiation, suggesting that WNT4 actively represses elements of the male pathway during ovarian development. Here, we show that follistatin (Fst), which encodes a TGFbeta superfamily binding protein, is a downstream component of Wnt4 signaling. Fst inhibits formation of the XY-specific coelomic vessel in XX gonads. In addition, germ cells in the ovarian cortex are almost completely lost in both Wnt4 and Fst null gonads before birth. Thus, we propose that WNT4 acts through FST to regulate vascular boundaries and maintain germ cell survival in the ovary.